Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial

25 May 2019 (16:42 - 16:48)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail

The discriminative power and optimal diagnostic thresholds of NT-proBNP in patients admitted with acute heart failure-related signs and symptoms: a prospective observational study

Doctor P. Simitsis (Athens, GR)

Presentation thumbnail

Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique and NT-proBNP. Results of IMPEDANCE-HF extended trial

Professor M. Kleiner Shochat (Hadera, IL)

Abstract Slides Video

Presentation thumbnail

BIS equation of glomerular filtration rate in the prediction of hospitalization and mortality in older patients with heart failure

Doctor J. Santos (Viseu, PT)

Abstract Slides Video

Presentation thumbnail

Incident hyperkalemia and RAAS-inhibition during an acute heart failure hospitalization

Mr J. Beusekamp (Groningen, NL)

Presentation thumbnail

Concurrent Initiation of Intra-aortic Balloon Pumping with Extracorporeal Membrane Oxygenation Reduced In-hospital Mortality in Postcardiotomy Cardiogenic Shock

Doctor K. Chen (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Rapid Fire 3 - Acute heart failure

The Event

Heart Failure 2019

25 May 2019 16:42 CET

You may be interested in

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

Congress Session

Devices in acute heart failure

Congress Session

Acute heart failure: what to watch for

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources